Similar companies
Income Statement (USD)
| Q3 '24 | QoQ | |
|---|---|---|
| Revenue | 7.4M | 18.7% |
| Gross Profit | 3.9M | 40.7% |
| Cost of Revenue | 14M | 12.8% |
| Operating expense | 16M | 16% |
| Net Income | -12M | 9.4% |
| EBITDA | -10M | 32.1% |
Balance Sheet (USD)
| Q3 '24 | QoQ | |
|---|---|---|
| Total Assets | 110M | 10% |
| Total Liabilities | 51M | 4.9% |
| Total Equity | 59M | 14% |
| Shares Outstanding | 31M | 4.3% |
Cash Flow (USD)
| Q3 '24 | QoQ | |
|---|---|---|
| Cash from operations | -7.4M | 35.3% |
| Cash from investing | -32,000 | 10.3% |
EPS
Financial Highlights for DarioHealth in Q3 '24
DarioHealth reported a revenue of 7.4M, which is a 18.7% change from the previous quarter. An increase in revenue typically indicates growing demand for the company's products or services. This positive change in revenue is a good sign, suggesting that the company's sales are moving in the right direction.
Gross Profit stood at 3.9M, marking a 40.7% change since the last quarter. Gross profit showcases the efficiency in production and sales processes.
Cost of Revenue was 14M, a -12.8% difference from the previous quarter. A rising cost of revenue may suggest increased production or sales costs, which can impact margins. However, if accompanied by a proportionate rise in revenue, it could indicate scaling operations.
Operating Expenses for this period were 16M, showing a -16% change from the last quarter. Operating expenses cover the costs of running daily business operations. A significant increase might indicate inefficiencies or investments in growth, while a decrease could suggest cost-saving measures or potential underinvestment in key areas.
Net Income for the quarter was -12M, showing a 9.4% change from the prior quarter. Net income provides a clear picture of the company's profitability after all expenses. An increase suggests the company is becoming more profitable, while a decrease may raise concerns about the company's financial health, unless there are specific one-time costs or investments.
The company's EBITDA for the quarter was -10M, showing a 32.1% change from the previous period. EBITDA gives insight into the company's operational profitability, excluding non-operating expenses like interest and taxes. A rising EBITDA indicates strong operational performance, while a declining EBITDA may signal operational challenges or increased costs.
It was a positive quarter for DarioHealth with growth in revenue, gross profit, and net income.
